Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice
- PMID: 31553175
- DOI: 10.1021/acs.bioconjchem.9b00505
Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice
Abstract
Lower generation PAMAM dendrimers have an immense potential for drug delivery with lower toxicity, but these dendrimers yet need certain basic ameliorations. In this study, the brain delivery potential of the synthesized PAMAM-Lf (lower generation PAMAM and lactoferrin conjugate) loaded with memantine (MEM) was explored and evaluated in vitro and in vivo in the disease-induced mouse model. The developed nanoscaffolds were characterized for size, zeta potential and in vitro release. Increase in the average size from 11.54 ± 0.91 to 131.72 ± 4.73 nm, respectively, was observed for drug-loaded PAMAM (i.e., PAMAM-MEM) and PAMAM-Lf (i.e., MEM-PAMAM-Lf). Release profile of MEM from MEM-PAMAM-Lf was slow and sustained up to 48 h. In vivo biodistribution in the Sprague-Dawley rat model revealed that the brain uptake of MEM-PAMAM-Lf was significantly higher than that of MEM alone. The behavioral response study in the healthy rats did not result in any significant changes. The in vivo study in an AlCl3-induced Alzheimer's (AD) mice model showed a significant improvement in behavioral responses. Optical density, which reflects the acetylcholinesterase (AChE) activity, was highest in the AL group 0.16 ± 0.01 (higher than the CON group, 0.09 ± 0.02; p < 0.05). No significant suppression of AChE activity was recorded in all the other treated groups. Similarly, the DOPAmine and 3,4 dihydroxyphenylacetic acid (DOPAC) levels were unaffected by the developed formulations. The study reported improved brain bioavailability of MEM in AlCl3-induced Alzheimer's mice leading to improved memory, with the resultant mechanism behind in a descriptive manner. This study is among the preliminary studies reporting the memory improvement aspect of PAMAM-Lf conjugates for MEM in AlCl3-AD induced mice. The formulation developed was beneficial in AD-induced mice and had a significant impact on the memory aspects.
Similar articles
-
Boosted Memory and Improved Brain Bioavailability of Rivastigmine: Targeting Effort to the Brain Using Covalently Tethered Lower Generation PAMAM Dendrimers with Lactoferrin.Mol Pharm. 2018 Oct 1;15(10):4538-4549. doi: 10.1021/acs.molpharmaceut.8b00537. Epub 2018 Aug 29. Mol Pharm. 2018. PMID: 30156844
-
Behavioral and Biochemical Implications of Dendrimeric Rivastigmine in Memory-Deficit and Alzheimer's Induced Rodents.ACS Chem Neurosci. 2019 Aug 21;10(8):3789-3795. doi: 10.1021/acschemneuro.9b00286. Epub 2019 Jul 30. ACS Chem Neurosci. 2019. PMID: 31257860
-
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.J Nanobiotechnology. 2018 Mar 27;16(1):32. doi: 10.1186/s12951-018-0356-z. J Nanobiotechnology. 2018. PMID: 29587747 Free PMC article.
-
Use of Polyamidoamine Dendrimers in Brain Diseases.Molecules. 2018 Sep 3;23(9):2238. doi: 10.3390/molecules23092238. Molecules. 2018. PMID: 30177605 Free PMC article. Review.
-
New Advances in General Biomedical Applications of PAMAM Dendrimers.Molecules. 2018 Nov 2;23(11):2849. doi: 10.3390/molecules23112849. Molecules. 2018. PMID: 30400134 Free PMC article. Review.
Cited by
-
Breaking Barriers in Alzheimer's Disease: the Role of Advanced Drug Delivery Systems.AAPS PharmSciTech. 2024 Sep 5;25(7):207. doi: 10.1208/s12249-024-02923-6. AAPS PharmSciTech. 2024. PMID: 39237748 Review.
-
Dendrimers-Novel Therapeutic Approaches for Alzheimer's Disease.Biomedicines. 2024 Aug 20;12(8):1899. doi: 10.3390/biomedicines12081899. Biomedicines. 2024. PMID: 39200363 Free PMC article. Review.
-
Current Overview on the Use of Nanosized Drug Delivery Systems in the Treatment of Neurodegenerative Diseases.ACS Omega. 2024 Aug 5;9(33):35223-35242. doi: 10.1021/acsomega.4c01774. eCollection 2024 Aug 20. ACS Omega. 2024. PMID: 39184484 Free PMC article. Review.
-
Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer's Disease and Phytochemicals-Based Interventions.Mol Neurobiol. 2024 Oct;61(10):8320-8343. doi: 10.1007/s12035-024-04053-3. Epub 2024 Mar 16. Mol Neurobiol. 2024. PMID: 38491338 Review.
-
Recent progresses in natural based therapeutic materials for Alzheimer's disease.Heliyon. 2024 Feb 15;10(4):e26351. doi: 10.1016/j.heliyon.2024.e26351. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38434059 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical